Biphasic neurovascular changes in prolonged migraine aura in familial hemiplegic migraine type 2

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 86, Issue 3, 2015, Pages 344-353

  Iizuka, Takahiro ^a   Tominaga, Naomi ^a   Kaneko, Juntaro ^a   Sato, Mayumi ^a   Akutsu, Tsugio ^a   Hamada, Junichi ^a   Sakai, Fumihiko ^b   Nishiyama, Kazutoshi ^a  

^a KITASATO UNIVERSITY   (Japan)

^b Saitama International Medical Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; FLUORODEOXYGLUCOSE F 18; LAMOTRIGINE; LOMERIZINE; METHYLPREDNISOLONE; PREDNISONE; TOPIRAMATE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ATP1A2 PROTEIN, HUMAN;

ACUTE DISEASE; ADULT; AGED; ARTICLE; ATP1A2 GENE; BRAIN BLOOD FLOW; BRAIN METABOLISM; BRAIN PERFUSION; CASE REPORT; CLINICAL FEATURE; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG TOLERABILITY; ELECTROENCEPHALOGRAM; FAMILIAL HEMIPLEGIC MIGRAINE; FATIGUE; FEMALE; GENE; GLUCOSE METABOLISM; HEMIPLEGIA; HEMIPLEGIC MIGRAINE WITH PROLONGED AURA; HEMISPHERE; HUMAN; INCREASED APPETITE; MAGNETIC RESONANCE ANGIOGRAPHY; MENTAL STRESS; MIDDLE AGED; MIGRAINE AURA; MUTATIONAL ANALYSIS; NEOVASCULARIZATION (PATHOLOGY); NEUROIMAGING; NEUROPROTECTION; POSITRON EMISSION TOMOGRAPHY; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOM; TREATMENT RESPONSE; Z SCORE; ALPHA RHYTHM; BLOOD FLOW; BRAIN; BRAIN ISCHEMIA; COMPUTER ASSISTED DIAGNOSIS; ELECTROENCEPHALOGRAPHY; GENETICS; HEMISPHERIC DOMINANCE; HETEROZYGOTE DETECTION; HYPEREMIA; MIGRAINE WITH AURA; NEUROLOGIC EXAMINATION; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PEDIGREE; PHYSIOLOGY; THREE DIMENSIONAL IMAGING; VASCULARIZATION;

ADULT; AGED; ALPHA RHYTHM; BRAIN; BRAIN ISCHEMIA; DNA MUTATIONAL ANALYSIS; DOMINANCE, CEREBRAL; ELECTROENCEPHALOGRAPHY; FEMALE; HETEROZYGOTE DETECTION; HUMANS; HYPEREMIA; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; MIGRAINE WITH AURA; NEUROLOGIC EXAMINATION; PEDIGREE; POSITRON-EMISSION TOMOGRAPHY; REGIONAL BLOOD FLOW; SODIUM-POTASSIUM-EXCHANGING ATPASE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84923181299     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-307731     Document Type: Article

References (39)

1. Headache Classification Committee of the International Headache Society (IHS). The International classification of headache disorders. 3rd edn. (beta version). Cephalalgia, 2013;33:629-808.
2. Russell MB, Ducros A. Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol 2011;10:457-70.
3. Viana MI, Sprenger T, Andelova M, et al. The typical duration of migraine aura: a systematic review. Cephalalgia 2013;33:483-90.
4. Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain 1994;117:199-210.
5. Hadjikhani N, Sanchez Del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 2001;98:4687-92.
6. Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca(2+) channel gene CACNL1A4. Cell 1996;87:543-52.
7. De Fusco M, Marconi R, Silvestri L, et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha-2 subunit associated with familial hemiplegic migraine type 2. Nature Genet 2003;33:192-6.
8. Dichgans M, Freilinger T, Eckstein G, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 2005;366:371-7.
9. Moskowitz MA, Bolay H, Dalkara T. Deciphering migraine mechanisms: clues from familial hemiplegic migraine genotypes. Ann Neurol 2004;55:276-80.
10. Eikermann-Haerter K, Yuzawa I, Qin T, et al. Enhanced subcortical spreading depression in familial hemiplegic migraine type 1 mutant mice. J Neurosci 2011;31:5755-63.
11. Kraus J, Golaszewski S, Luthringshausen G, et al. Prolonged migrainous aura and acute ischemic insult. Differential diagnosis by diffusion- and perfusion-weighted cMRI. Nervenarzt 2007;78:1420-4.
12. Hansen JM, Schytz HW, Larsen VA, et al. Hemiplegic migraine aura begins with cerebral hypoperfusion: imaging in the acute phase. Headache 2011;51:1289-96.
13. Mourand I, Menjot de Champfleur N, Carra-Dallière C, et al. Perfusion-weighted MR imaging in persistent hemiplegic migraine. Neuroradiology 2012;54:255-60.
14. Aminian A, Strashun A, Rose A. Alternating hemiplegia of childhood: studies of regional cerebral blood flow using 99mTc-hexamethylpropylene amine oxime single-photon emission computed tomography. Ann Neurol 1993;33:43-7.
15. Masuzaki M, Utsunomiya H, Yasumoto S, et al. A case of hemiplegic migraine in childhood: transient unilateral hyperperfusion revealed by perfusion MR imaging and MR angiography. AJNR Am J Neuroradiol 2001;22:1795-7.
16. Smith M, Cros D, Sheen V. Hyperperfusion with vasogenic leakage by fMRI in migraine with prolonged aura. Neurology 2002;58:1308-10.
17. Lindahl AJ, Allder S, Jefferson D, et al. Prolonged hemiplegic migraine associated with unilateral hyperperfusion on perfusion weighted magnetic resonance imaging. J Neurol Neurosurg Psychiatry 2002;73:202-3.
18. Oberndorfer S, Wober C, Nasel C, et al. Familial hemiplegic migraine: follow-up findings of diffusion-weighted magnetic resonance imaging (MRI), perfusion-MRI and [99mTc] HMPAO-SPECT in a patient with prolonged hemiplegic aura. Cephalalgia 2004;24:533-9.
19. Iizuka T, Sakai F, Suzuki K, et al. Implication of augmented vasogenic leakage in the mechanism of persistent aura in sporadic hemiplegic migraine. Cephalalgia 2006;26:332-5.
20. Lanfranconi S, Corti S, Bersano A, et al. Aphasic and visual aura with increased vasogenic leakage: an atypical migrainosus status. J Neurol Sci 2009; 285:227-9.
21. Mourand I, Menjot de Champfleur N, Carra-Dallière C, et al. Perfusion-weighted MR imaging in persistent hemiplegic migraine. Neuroradiology 2012;54:255-60.
22. Iizuka T, Takahashi Y, Sato M, et al. Neurovascular changes in prolonged migraine aura in FHM with a novel ATP1A2 gene mutation. J Neurol Neurosurg Psychiatry 2012;83:205-12.
23. Gastaut JL, Yermenos E, Bonnefoy M, et al. Familial hemiplegic migraine: EEG and CT scan study of two cases. Ann Neurol 1981;10:392-5.
24. Andersen AR, Friberg L, Olsen TS, et al. Delayed hyperemia following hypoperfusion in classic migraine. Single photon emission computed tomographic demonstration. Arch Neurol 1988;45:154-9.
25. Eikermann-Haerter K, Negro A, Ayata C. Spreading depression and the clinical correlates of migraine. Rev Neurosci 2013;24:353-63.
26. Relja G, Granato A, Ukmar M, et al. Persistent aura without infarction: decription of the first case studied with both brain SPECT and perfusion MRI. Cephalalgia 2005;25:56-9.
27. Dodgson SJ, Shank RP, Maryanoff BE. Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 2000;41(Suppl 1):S35-39.
28. Hara H, Morita T, Sukamoto T, et al. Lomerizine (KB-2796), a new antimigraine drug. CNS Drug Rev 1995;1:204-26.
29. Hamel E. Perivascular nerves and the regulation of cerebrovascular tone. J Appl Physiol 2006;100:1059-64.
30. Fellin T, Sul JY, D'Ascenzo M, et al. Bidirectional astrocyte-neuron communication: the many roles of glutamate and ATP. Novartis Found Symp 2006;276:208-17.
31. Ben Achour S, Pascual O. Astrocyte-neuron communication: functional consequences. Neurochem Res 2012;37:2464-73.
32. Goadsby PJ. Autonomic nervous system control of the cerebral circulation. Handb Clin Neurol 2013;117:193-201.
33. Zhang X, Levy D, Noseda R, et al. Activation of meningeal nociceptors by cortical spreading depression: implications for migraine with aura. J Neurosci 2010;30:8807-14.
34. Zhang X, Levy D, Kainz V, et al. Activation of central trigeminovascular neurons by cortical spreading depression. Ann Neurol 2011;69:855-65.
35. Jakovcevic D, Harder DR. Role of astrocytes in matching blood flow to neuronal activity. Curr Top Dev Biol 2007;79:75-97.
36. Pellerin L, Bouzier-Sore AK, Aubert A, et al. Activity-dependent regulation of energy metabolism by astrocytes: an update. Glia 2007;55:1251-62.
37. Leo L, Gherardini L, Barone V, et al. Increased susceptibility to cortical spreading depression in the mouse model of familial hemiplegic migraine type 2. PLoS Genet 2011;7:e1002129.
38. Gritz SM, Radcliffe RA. Genetic effects of ATP1A2 in familial hemiplegic migraine type II and animal models. Hum Genomics 2013;7:8.
39. Barros J, Mendes A, Matos I, et al. Psychotic aura symptoms in familial hemiplegic migraine type 2 (ATP1A2). J Headache Pain 2012; 13:581-5.